Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial

Author:

Harris Victoria,Holmes Jane,Gbinigie-Thompson Oghenekome,Rahman Najib M,Richards Duncan B,Hayward Gail,Dorward Jienchi,Lowe David M,Standing Joseph F,Breuer Judith,Khoo Saye,Petrou Stavros,Hood Kerenza,Ahmed Haroon,Carson-Stevens Andrew,Nguyen-Van-Tam Jonathan S,Patel Mahendra G,Saville Benjamin R,Francis Nick,Thomas Nicholas P B,Evans Philip,Dobson Melissa,Png May Ee,Lown Mark,van Hecke Oliver,Jani Bhautesh D,Hart Nigel D,Butler Daniel,Cureton Lucy,Patil Meena,Andersson Monique,Coates Maria,Bateman Clare,Davies Jennifer C,Raymundo-Wood Ivy,Ustianowski Andrew,Yu Ly-Mee,Hobbs F D Richard,Little Paul,Butler Christopher C,Moftah Areej,Goodman Anna,Halifax Rob,Turnbull Chris,Sundaralingam Anand,Agyeman Akosua,Shah Divya,Brown Julianne,Thalasselis Chris,Woodall Maximillian N J,Yongblah Francis,Howell Aleksandra,Patel Kavil,Hussain Iqbal,Penfold Ruth,Hutchinson Simon,Poonian Satveer,Imlach Marie,Popoola Olajide,Irving Greg,Pora Alexander,Jacobsen Nicholas,Prasad Vibhore,Kennard James,Prasad Rishabh,Khan Umar,Razzaq Omair,Knox Kyle,Richardson Scot,Krasucki Christopher,Royal Simon,Law Tom,Safa Afsana,Lee Rem,Sehdev Satash,Lester Nicola,Sevenoaks Tamsin,Lewis David,Sheikh Aadil,Lunn James,Short Vanessa,Mackintosh Claire,Singh Sidhu Baljinder,Mathukia Mehul,Singh Ivor,Moore Patrick,Soni Yusuf,Morton Seb,Wilson Pete,Murphy Daniel,Wingfield David,Nally Rhiannon,Wong Michael,Ndukauba Chinonso,Wooding Nick,Ogundapo Olufunto,Woods Sharon,Okeke Henry,Yong Joanna,Ahmed Tanveer,Allcock Damien,Atherton George,Beltran-Martinez Adrian,Benedict Oluseye Emmanuel,Bird Nigel,Brennan Laura,Burns Gerard,Butler Mike,Butler Daniel,Carson-Stevens Andrew,Cheng Zelda,Danson Ruth,De Kare-Silver Nigel,Dhasmana Devesh,Dickson Jon,Engamba Serge,Fisher Stacey,Fox Robin,Frost Eve,Gaunt Richard,Ghosh Sarit,Gilkar Ishtiaq,Goodman Anna,Granier Steve,Packham Alice,Dowsell Sarah,Gulati Radhika,Patel Amit

Funder

NIHR

Publisher

Elsevier BV

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. SARS-CoV-2 antivirals and post-COVID-19 condition;The Lancet Infectious Diseases;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3